title: Cancer genomics: conducting exemplary trials with biospecimen and biomarker components.
abstract: Translating research on genomic changes into novel interventions for patients with cancer requires increased analysis of biospecimens and biomarkers in cancer clinical trials, which involve certain procedural requirements.
authors.affiliation: American Society of Clinical Oncology, Alexandria, VA; Patient Advocates in Research, Danville, CA; Research Advocacy Network, Plano, TX; and Sarah Cannon Research Institute, Nashville, TN.
authors.forename: Allison R
authors.initials: AR
authors.lastname: Baer
authors.forename: Deborah
authors.initials: D
authors.lastname: Collyar
authors.forename: Mary Lou
authors.initials: ML
authors.lastname: Smith
authors.forename: Johanna
authors.initials: J
authors.lastname: Bendell
references.citation: N Engl J Med. 2005 Oct 20;353(16):1673-84
references.pmid: 16236738
references.citation: J Clin Oncol. 2006 Jun 20;24(18):2707-14
references.pmid: 16782910
references.citation: J Clin Oncol. 2008 May 20;26(15):2562-7
references.pmid: 18390967
references.citation: N Engl J Med. 2009 Apr 2;360(14):1408-17
references.pmid: 19339720